HZNP logo

HZNP

Profile

Full Name

Horizon Therapeutics Public Limited Company

Ticker Symbol

HZNP

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

Ireland

IPO

July 28, 2011

Indexes

Not included

Website

http://www.horizontherapeutics.com

Employees

2190

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.63B(+12.48% YoY)

Annual EPS

$2.22(-2.20% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

-
HZNP price value is unknown

30-Day Relative Volume

-
HZNP 30-day relative volume value is unknown

Price Performance

Price Most recent change

-
HZNP price change on Jan 1, 1 is unknown

Price YTD change

-
HZNP price ytd change is unknown

Price 1-year change

-
HZNP price 1-year change is unknown

Price 3-year change

-
HZNP price 3-year change is unknown

Price Range

Price All-time high

$116.30
HZNP price is currently at an all-time high

Price 3-year low

$116.30
HZNP price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

-
HZNP market capitalization value is unknown

Market cap 3-year change

-
HZNP market capitalization 3-year change is unknown

Market cap All-time high

$26.63B
HZNP market capitalization is currently at an all-time high

Market cap sector rank

-
HZNP market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

0%
HZNP {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

-0.22%
HZNP shares outstanding is down -0.22% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-
HZNP beta value is unknown

200-day SMA

-
HZNP SMA 200 is unknown

50-day SMA

-
HZNP SMA 50 is unknown

RSI

-
HZNP 14-day relative strength index value is unknown

Volume

-
HZNP 30-day relative volume value is unknown

ATR

-
HZNP average true range value is unknown

10-day Historical Volatility

-
HZNP 10-day historical volatility value is unknown

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.63B
HZNP annual revenue is $3.63 billion

Revenue Analysts estimate

$3.77B
HZNP annual revenue is currently -3.77% lower than the consensus analysts' forecast

Revenue 1-year change

+12.48%
HZNP annual revenue is up +12.48% year-on-year

Revenue Sector rank

-
HZNP annual revenue is unknown

EPS

EPS

$2.22
HZNP annual earnings per share is $2.22

EPS Analysts estimate

$4.64
HZNP annual earnings per share is currently -52.16% lower than the consensus analysts' forecast

EPS 1-year change

-2.2%
HZNP annual earnings per share is down -2.2% year-on-year

EPS Sector rank

-
HZNP annual earnings per share is unknown

Profit

Gross profit

$2.71B
HZNP annual gross profit is $2.71 billion

Gross margin

74.64%
HZNP annual gross profit margin is 74.64%

Operating profit

$729.83M
HZNP annual operating income is $729.83 million

Operating margin

20.11%
HZNP annual operating profit margin is 20.11%

Net income

$521.48M
HZNP annual net profit is $521.48 million

Net margin

14.37%
HZNP annual net profit margin is 14.37%

Expenses

Total expenses

$2.90B
HZNP annual total expenses is $2.90 billion

Operating expenses

$1.98B
HZNP annual total operating expenses is $1.98 billion

Cost of goods sold

$920.20M
HZNP annual cost of goods sold is $920.20 million

Selling, general & administrative expenses

$1.54B
HZNP annual SGA is $1.54 billion

Depreciation and amortization

$390.39M
HZNP annual depreciation & amortization is $390.39 million

Interest expense

$83.71M
HZNP annual interest expense is $83.71 million

Income tax

$5.45M
HZNP annual income tax is $5.45 million

EBIT & EBITDA

EBIT

$610.64M
HZNP annual earnings before interest & taxes is $610.64 million

EBITDA

$1.00B
HZNP annual EBITDA is $1.00 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$9.11B
HZNP annual total assets is $9.11 billion

Non current assets

$4.45B
HZNP annual long term assets is $4.45 billion

Current assets

$3.65B
HZNP annual total current assets is $3.65 billion

Cash and cash equivalents

$2.35B
HZNP annual cash & cash equivalents is $2.35 billion

Accounts receivable

$676.35M
HZNP annual accounts receivable is $676.35 million

Inventory

$169.56M
HZNP annual inventory is $169.56 million

Liabilities

Total liabilities

$4.04B
HZNP annual total liabilities is $4.04 billion

Long term liabilities

$3.09B
HZNP annual total long term liabilities is $3.09 billion

Current liabilities

$949.14M
HZNP annual total current liabilities is $949.14 million

Accounts payable

$155.80M
HZNP annual accounts payable is $155.80 million

Debt

Total debt

$2.58B
HZNP annual total debt is $2.58 billion

Total debt 1-year change

-0.32%
HZNP annual total debt is down -0.32% year-on-year

Long term debt

$2.56B
HZNP annual long term debt is $2.56 billion

Short term debt

$16.00M
HZNP annual short term debt is $16.00 million

Equity & Capital

Shareholders equity

$5.07B
HZNP annual stockholders equity is $5.07 billion

Book value

$5.07B
HZNP annual book value is $5.07 billion

Retained earnings

$590.01M
HZNP annual retained earnings is $590.01 million

Working capital

$2.70B
HZNP annual working capital is $2.70 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.26B
HZNP annual cash flow from operations is $1.26 billion

Cash from operations 1-year change

+21.5%
HZNP annual cash flow from operations is up +21.5% year-on-year

Cash from investing

-$134.00M
HZNP annual cash flow from investing activities is -$134.00 million

Cash from investing 1-year change

+95.52%
HZNP annual cash flow from investing activities is up +95.52% year-on-year

Cash from financing

-$347.96M
HZNP annual cash flow from financing activities is -$347.96 million

Cash from financing 1-year change

-123.67%
HZNP annual cash flow from financing activities is down -123.67% year-on-year

CAPEX

CAPEX

$126.28M
HZNP annual capital expenditures is $126.28 million

CAPEX 1-year change

-1.48%
HZNP annual capital expenditures is down -1.48% year-on-year

Free Cash Flow

Free cash flow

$1.13B
HZNP annual free cash flow is $1.13 billion

Free cash flow 1-year change

+24.75%
HZNP annual free cash flow is up +24.75% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

74.64%
HZNP annual gross profit margin is 74.64%

Operating margin

20.11%
HZNP annual operating profit margin is 20.11%

Net margin

14.37%
HZNP annual net profit margin is 14.37%

ROA & ROE

ROA

5.86%
HZNP annual return on assets is 5.86%

ROE

10.70%
HZNP annual return on equity is 10.70%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
HZNP price to earnings ratio value is unknown

PE ratio Sector rank

-
HZNP price to earnings ratio is unknown

PB Ratio

PB ratio

-
HZNP price to book ratio value is unknown

PB ratio Sector rank

-
HZNP price to book ratio is unknown

PS Ratio

PS ratio

-
HZNP price to sales ratio value is unknown

PS ratio Sector rank

-
HZNP price to sales ratio is unknown

Enterprise value

Enterprise value

-
HZNP enterprise value value is unknown

Enterprise value Sector rank

-
HZNP enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
HZNP EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
HZNP EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.85
HZNP annual current ratio is 3.85

Quick ratio

3.67
HZNP annual quick ratio is 3.67

Leverage

Debt to equity

0.51
HZNP annual debt to equity ratio is 0.51

Interest coverage ratio

7.30
HZNP annual interest coverage ratio is 7.30

Risk & Stability

Piotroski F-Score

8
HZNP piotroski f-score is 8

Altman Z-Score

-
HZNP altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 13, 22 Wells Fargo
Equal-Weight
Dec 13, 22 SVB Leerink
Market Perform
Dec 13, 22 Guggenheim
Neutral
Dec 13, 22 BMO Capital
Market Perform
Dec 12, 22 Stifel
Hold
Dec 7, 22 Piper Sandler
Overweight
Nov 3, 22 SVB Leerink
Outperform
Nov 1, 22 HC Wainwright & Co.
Neutral
Oct 25, 22 Piper Sandler
Overweight
Aug 4, 22 UBS
Neutral

Institutional Ownership

Similar stocks

  • What is the ticker symbol for Horizon Therapeutics Public Limited?
  • Does Horizon Therapeutics Public Limited pay dividends?
  • What sector is Horizon Therapeutics Public Limited in?
  • What industry is Horizon Therapeutics Public Limited in?
  • What country is Horizon Therapeutics Public Limited based in?
  • When did Horizon Therapeutics Public Limited go public?
  • Is Horizon Therapeutics Public Limited in the S&P 500?
  • Is Horizon Therapeutics Public Limited in the NASDAQ 100?
  • Is Horizon Therapeutics Public Limited in the Dow Jones?
  • When was Horizon Therapeutics Public Limited's last earnings report?
  • When does Horizon Therapeutics Public Limited report earnings?
  • Should I buy Horizon Therapeutics Public Limited stock now?

What is the ticker symbol for Horizon Therapeutics Public Limited?

The ticker symbol for Horizon Therapeutics Public Limited is NASDAQ:HZNP

Does Horizon Therapeutics Public Limited pay dividends?

No, Horizon Therapeutics Public Limited does not pay dividends

What sector is Horizon Therapeutics Public Limited in?

Horizon Therapeutics Public Limited is in the Healthcare sector

What industry is Horizon Therapeutics Public Limited in?

Horizon Therapeutics Public Limited is in the Drug Manufacturers - General industry

What country is Horizon Therapeutics Public Limited based in?

Horizon Therapeutics Public Limited is headquartered in Ireland

When did Horizon Therapeutics Public Limited go public?

Horizon Therapeutics Public Limited's initial public offering (IPO) was on July 28, 2011

Is Horizon Therapeutics Public Limited in the S&P 500?

No, Horizon Therapeutics Public Limited is not included in the S&P 500 index

Is Horizon Therapeutics Public Limited in the NASDAQ 100?

No, Horizon Therapeutics Public Limited is not included in the NASDAQ 100 index

Is Horizon Therapeutics Public Limited in the Dow Jones?

No, Horizon Therapeutics Public Limited is not included in the Dow Jones index

When was Horizon Therapeutics Public Limited's last earnings report?

Horizon Therapeutics Public Limited's most recent earnings report was on Nov 2, 2023

When does Horizon Therapeutics Public Limited report earnings?

The date for Horizon Therapeutics Public Limited's next earnings report has not been announced yet

Should I buy Horizon Therapeutics Public Limited stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page